English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduBrazilian researchers surveyed 900 volunteers via an online platform for five months. Most reported feeling that time passed more slowly during home confinement in the early months of the pandemic, associating this perception with feelings of loneliness.
Tag: COVID -19
COVID-19 Fattens Up Our Body’s Cells to Fuel Its Viral Takeover
The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.
Canada’s COVID-19 response in first 2 years of pandemic compares well with other countries’ measures
Compared with other G10 countries, Canada handled the first 2 years of the COVID-19 pandemic well by most measures, according to an analysis in CMAJ (Canadian Medical Association Journal).
The surprising link between SARS-CoV-2 infection and new-onset diabetes
Researchers from Osaka University find that infection with SARS-CoV-2 activates the IRF1 gene and impairs insulin/IGF signaling in the lung, liver, adipose tissue, and pancreatic cells
Newer COVID-19 Subvariants Are Less Vulnerable to Immunity Induced by Vaccination and Previous Infection, Researchers Find
In a letter published in the New England Journal of Medicine, physician-scientists report that the three Omicron subvariants currently dominant in the United States – officially known as subvariants BA.2.12.1, BA.4, and BA.5 – substantially escape neutralizing antibodies induced by both vaccination and previous infection.
Mount Sinai Researchers Develop Machine Learning Model that Can Detect and Predict COVID-19 from Collected Data on Wearable Devices
Mount Sinai researchers have developed a machine learning algorithm that can determine if an individual has SARS-CoV-2 infections, the virus that causes COVID-19—with a high sensitivity and specificity—from the data collected by wearable devices.
New study finds COVID-19 booster increases antibodies by more than 85% in nursing home residents and their caregivers
The study found that Omicron-specific antibodies reached detectable levels in 86% of nursing home residents and 93% of healthcare workers after receiving the booster shot, compared to just 28% of nursing home residents and healthcare workers after the initial two-dose COVID-19 vaccine series.
Rensselaer Researchers Make Virus-Fighting Face Masks
Rensselaer Polytechnic Institute researchers have developed an accessible way to make N95 face masks not only effective barriers to germs, but on-contact germ killers. The antiviral, antibacterial masks can potentially be worn longer, causing less plastic waste as the masks do not need to be replaced as frequently.
Study in Chinese City Finds Children Spread COVID-19 Easier and Lockdowns Worked
Using high quality COVID-19 data from a northern Chinese city, two UAlbany researchers concluded that young people were most responsible for an increase in direct and secondary infections, and also determined that county-wide lockdowns proved effective in stemming the spread of the virus.
University of Pennsylvania’s First NFT Commemorates mRNA Research
The historic scientific breakthrough at the Perelman School of Medicine at the University of Pennsylvania that helped lead the world’s fight against COVID-19 through mRNA-based vaccines is being commemorated through a non-fungible token—a digital asset to be auctioned by Christie’s—that will support ongoing research at Penn.
Long COVID and the digestive system: Mayo Clinic expert describes common symptoms
Long COVID syndrome, also known as post-COVID, is more than fatigue and shortness of breath. Symptoms such as headaches, brain fog and ringing in the ears have been reported, and recently, physicians are seeing more patients with gastrointestinal problems.
Post-COVID, what’s the role of religion?
International researchers in four countries of the “Global North,” including Canada, are looking into how majority and majority faiths are dealing with life after the pandemic.
Broadly neutralizing antibodies could provide immunity against SARS-CoV-2 variants
Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM). The antibodies were effective against all SARS-CoV-2 variants of concern tested and could be used alone or in an antibody cocktail to diminish the risk of infection.
Loyola Medicine Pediatric Experts Available to Discuss Possible Approval of COVID-19 Vaccines for Children Under 5
MAYWOOD, IL – Panels from the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) are meeting this week to consider authorizing COVID-19 vaccines for children under the age of 5 from both Pfizer and Moderna. The…
New research at UH Rainbow Babies & Children’s Hospital evaluates critical illness from COVID-19 vs influenza in children
Researchers at UH Rainbow published new findings that COVID-19 is not equivalent to flu infection for children. Among 66 pediatric ICUs in the US, the number admitted each quarter with COVID-19 or MIS-C during the first 15 months of the pandemic was twice as high as that for flu pre-pandemic.
SEIR Model to Address the Impact of Face Masks amid COVID-19 Pandemic
When vaccines are not available, alternative strategies are required to decrease SARS-CoV-2 transmission. Behavior of the population and government regulations, such as hand hygiene, quarantine of exposed persons, isolation of symptomatic persons, and travel restriction, play an essential role in…
Mount Sinai Researchers Develop a Rapid Test to Measure Immunity to COVID-19
Mount Sinai researchers have developed a rapid blood assay that measures the magnitude and duration of someone’s immunity to SARS-CoV-2, the virus that causes COVID-19. This test will allow large-scale monitoring of the population’s immunity and the effectiveness of current vaccines to help design revaccination strategies for vulnerable immunosuppressed individuals, according to a study published in Nature Biotechnology in June.
COVID-19 Pandemic Increases Employment Disruptions Due to Childcare Insecurity
A study published in JAMA Pediatrics shows how frequently childcare insecurity during the COVID-19 pandemic occurred and the effect it had on parental job loss.
Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.
Global Study Finds Healthy Eating Got Pricier in the Pandemic
A new study compared the retail prices of eight food groups and overall consumer prices in 180 countries between January 2019 and June 2021, and found that the cost of groceries rose in tandem with COVID-19 case counts across the globe.
COVID-19 pandemic stress impacts ovulation
Life disruptions and the stresses of the COVID-19 pandemic led to disturbed ovulation with decreased progesterone durations or levels, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
COVID-19 vaccination appears to be safe for patients treated for hypothyroidism
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism,
according to a new study being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. The study found these vaccines do not cause significant fluctuations in thyroid function and are not associated with increased risks of emergency department visits or unscheduled hospitalizations.
Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.
Heart Failure Patients Unvaccinated Against COVID-19 Are Three Times More Likely to Die From It Than Boosted Heart Failure Patients
EMBARGOED UNTIL JUNE 9, 2022, 10AM EST (New York, NY – June 9, 2022) – Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus…
Rapid, reliable test for COVID and other infections, created by McMaster researchers, moves toward marketplace
McMaster University researchers behind a new form of rapid, accurate and portable diagnostic test are moving their work toward the marketplace.
Mammography screening and related breast care still rebounding from COVID-19 pandemic
According to a new study, use of breast imaging services – including mammography screening – may remain at only 85.3% of pre-pandemic utilization.
Cleveland Clinic Researchers Find Sleep Disturbances Prevalent in Post-Acute Sequelae of COVID-19 (PASC)
Cleveland Clinic researchers found more than 40% of patients with Long COVID (Post-Acute Sequelae of COVID-19 or PASC) had moderate to severe sleep disturbances. The analysis also showed patients with moderate-to-severe compared with normal-to-mild sleep disturbances had higher body mass…
Vaccines have up to 90% efficacy against severe COVID-19 for up to six months
Protection against symptomatic COVID-19 begins to decrease after one month from initial vaccination, while immunity against severe COVID-19 remains high for about six months, according to a recent study by Penn State College of Medicine scientists.
Study: Halt to In-Person Visits Due to Covid-19 Did Not Affect Knee Replacement Outcomes at Hospital for Special Surgery
A study at Hospital for Special Surgery (HSS) found that halting in-person postoperative visits in March 2020 due to COVID-19 did not lead to a higher complication rate, nor did it affect patient-reported outcomes after knee replacement surgery.
Striking Biological Gold
MassCPR biospecimens program will propel research on COVID-19 and beyond
Mount Sinai Researchers Awarded $16 Million to Develop Antivirals Against Viruses With Pandemic Potential
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded an initial $16 million from the National Institutes of Health (NIH) to discover and develop globally accessible and affordable novel oral antivirals to combat COVID-19 and future pandemics.
HOW WILL HUMANS SURVIVE A GLOBAL CATASTROPHE?
One suggested way to save humankind in the event of a deadly pandemic or other extreme global catastrophe is establishing a safe refuge – on an island or in such far-out places as the moon or under water — where a portion of the human population can stay alive.
LJI scientists publish first head-to-head comparison of four COVID-19 vaccines
“Just understanding the immune responses to these vaccines will help us integrate what is successful into vaccine designs going forward.”
COVID-19 antibodies can last up to 500 days after infection
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
Americans More Likely to Seek Surgical Care During a Pandemic if They and Hospital Staff are Vaccinated
Americans are more likely to have surgery during a pandemic such as COVID-19 if they are vaccinated, the hospital staff are vaccinated, the surgery is urgent or lifesaving (as opposed to elective), and the surgery is outpatient (i.e., not requiring an overnight stay), according to a new study published in Vaccine.
Academia, Pharma Team up to Discover New Drugs in Fight Against SARS-CoV-2, Viruses of the Future
Consortium of Hackensack Meridian CDI, Rockefeller University, Columbia University, Memorial Sloan Kettering Cancer Center, Rutgers University, Merck, Tri-Institutional Therapeutics Discovery Institute, Inc., and Aligos Therapeutics to combine expertise to ‘accelerate’ new breakthroughs
Frontier supercomputer debuts as world’s fastest, breaking exascale barrier
The Frontier supercomputer at the Department of Energy’s Oak Ridge National Laboratory earned the top ranking today as the world’s fastest on the 59th TOP500 list, with 1.1 exaflops of performance. The system is the first to achieve an unprecedented level of computing performance known as exascale, a threshold of a quintillion calculations per second.
Long COVID poses risks to vaccinated people, too
Vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System. However, a new study of more than 13 million veterans also found that vaccination against the virus that causes COVID-19 reduced the risk of death by 34% and the risk of getting long COVID-19 by 15%, compared with unvaccinated patients infected with the virus.
Most COVID-19 long-haulers continue to experience neurologic symptoms, fatigue, and compromised quality of life 15 months after initial infection
A new study published in Annals of Clinical and Translational Neurology looked at the evolution of neurologic symptoms in non-hospitalized COVID-19 long-haulers at the Northwestern Medicine Neuro COVID-19 Clinic and discovered most long-haulers continue to experience symptoms such as brain fog, numbness/tingling, headache, dizziness, blurred vision, tinnitus and fatigue on average of 15 months after disease onset.
New study informs mitigation strategies for contrast shortage in CT by identifying promising areas of focus
The current shortage of iodinated contrast in the United States due to the COVID-19 related production shutdown in China is causing severe disruptions in patient care. A new Harvey L. Neiman Health Policy Institute study outlines the most frequently used computed tomography services performed on Medicare beneficiaries as focus areas for mitigation strategies for the greatest overall impact.
Breakthrough COVID infections more likely in cancer and Alzheimer’s patients, studies find
Breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and Alzheimer’s patients, according to two new studies from researchers at the Case Western Reserve University School of Medicine.
Government Urged to Protect Riders – A New Economic Base Whose Lives Are Still Precarious and Uninsured
“Riders – Heroes – Chains,” a study from Chula that reflects a fast-growing modern workforce, especially during the COVID-19 pandemic but without assurance or protection of their welfare.
Monkeypox likely to elicit travel restrictions as WHO considers emergency declaration
Health authorities in Europe and the U.S. confirmed cases of monkeypox, a potentially serious viral illness, as the World Health Organization considers whether to declare an international emergency. Kathy Bergin, professor of disaster law at Cornell Law School, is an expert…
In STOP-COVID19 Trial, Brensocatib Did Not Improve Condition of Patients with Severe COVID-19
Brensocatib did not improve the clinical status of patients hospitalized with severe SARS-CoV-2 infection in the double-blind randomized, placebo-controlled STOP-COVID19 multicenter clinical trial, according to research published at the ATS 2022 international conference.
Imatinib Shows Improved Outcomes for Patients with Severe COVID-19 in the CounterCOVID Clinical Trial
Patients with severe COVID-19 who were given imatinib had lower mortality rates at 90-day follow-up, according to research published at the ATS 2022 international conference.
Many Historically “Redlined” California Communities Have Higher COVID-19 Incidence and Mortality
One of the legacies of “redlining” may be higher incidence and mortality rates of COVID-19 affecting the largely minority and poor residents of these neighborhoods, according to research published at the ATS 2022 international conference. ” Redlining is a Great Depression-era federal policy in which neighborhoods with large ethnic/racial minority groups were denied federal resources.
Mount Sinai Receives Landmark Gift from Royalty Pharma to Advance Health Equity
Marking a major advance in its efforts to achieve equity in the delivery of health care, the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) announced today that its Institute for Health Equity Research (IHER) has received a landmark $20 million gift over five years from Royalty Pharma plc (Nasdaq: RPRX) and certain members of its management team.
New Report Published Comparing Hemodynamics of Cardiac Shock in COVID-19 Patients in Pandemic’s First Vs. Second Wave
A new report by a team of cardiologists from the Heart & Vascular Hospital, Hackensack Meridian Hackensack University Medical Center that compares the hemodynamics of cardiac shock in patients with COVID-19 during the first versus the second wave of the COVID-19 pandemic was published recently in JACC: Journal of the American College of Cardiology.
Researchers on the Trail to Unraveling Long COVID-19
Long COVID-19 syndrome, in which symptoms last a year or longer beyond infection, impacts about 30 percent of survivors of the coronavirus.
Lina Shehadeh, Ph.D., professor of medicine in the Interdisciplinary Stem Cell Institute and Division of Cardiology at the University of Miami Miller School of Medicine, received a $1 million grant from the American Heart Association to study long COVID.
Outstanding Achievements of Distinguished Alumni Recognized with AU’s 2022 Alumni Awards
American University presented its 2022 Alumni Association Awards to five distinguished alumni — changemakers who are leaders in their communities and their fields.